AzTrials
AzTrials

Breast Feeding, ExclusiveMédiMATNCT07806942

Evaluation of a Health Mediation Program in the Maternity Ward.

An observational study of Breast Feeding, Exclusive, run by Centre Hospitalier de Cayenne at 1 site in French Guiana.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The first months of life are considered a critical period that has a lasting impact on a child's future health. Breastfeeding is one of the fundamental factors contributing to healthy growth in children. It is reducing infant mortality, and supporting neurocognitive development. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Breast Feeding, Exclusive
What is being tested?
postpartum breastfeeding support from a health mediator and routine health care without health mediation
How many people
960 participants
Where
1 siteFrench Guiana
Study dates
26 May 2026to 31 May 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Women who gave birth at the French Guiana University Hospital Center

Who may be able to join

  • Women who gave birth at the French Guiana University Hospital Center

Who cannot join

  • Women refusal to participate to the study or lack of opposition collected
  • lack of authorization from legal representatives for underage women or from legal guardians for women under legal protection
  • foetal death, stillbirth, or neonatal death
  • feeding with formula from birth

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

French Guiana1 site, 1 recruiting
  • Centre hospitalier de Cayenne

    Cayenne, Guyane, 97300

    Célia Célia BASURKO, MD, +594594395050, celia.basurko@ch-cayenne.fr

    Recruiting

Other trials in French Guiana

About this study

The first months of life are considered a critical period that has a lasting impact on a child's future health.

Breastfeeding is one of the fundamental factors contributing to healthy growth in children. It is reducing infant mortality, and supporting neurocognitive development.

Read more

As part of the Nutri Pou Ti'moun program, a study on breastfeeding practices was conducted in French Guiana in 2024 to assess the current state of affairs.

A complementary qualitative study of 15 mothers in situations of multidimensional vulnerability revealed barriers to exclusive breastfeeding, such as the perception of a lack of milk, the newborn's perceived refusal to breastfeed, or a lack of support from family and friends.

The findings of these 2 studies encourage the investigators to support mothers in their choice to breastfeed from the moment they give birth, so that infant feeding practices align more closely with national and international recommendations and are as beneficial as possible for the child's health.

The objective of this study is to compare the rate of exclusive breastfeeding at 1 month between women who received the intervention (exposed group) and those who did not (unexposed group).

The study hypothesis is that the health intervention will improve the rate of exclusive breastfeeding.

Read the detailed description

The first months of life are considered a critical period that has a lasting impact on a child's future health.

Breastfeeding is one of the fundamental factors contributing to healthy growth in children. Its benefits are well established in the literature in terms of preventing infections, reducing infant mortality, and supporting neurocognitive development.

As part of the Nutri Pou Ti'moun program, a study on breastfeeding practices was conducted in French Guiana in 2024 to assess the current state of affairs. Between March and October 2024, 382 mother-child pairs were included in this study. The results revealed that the majority of mothers had breastfed their children (91.6%) during the first year of life, but only 1 in 2 mothers had breastfed exclusively. Nearly 40% practiced mixed feeding upon discharge from the maternity ward. The study revealed that one in two women had received breastfeeding support from healthcare professionals at the maternity ward. This support tended to have a positive impact on the continuation of breastfeeding beyond 6 months. The use of formula milk supplements during the hospital stay, however, had a negative impact on the continuation of exclusive breastfeeding for at least 4 months.

A complementary qualitative study of 15 mothers in situations of multidimensional vulnerability revealed barriers to exclusive breastfeeding, such as the perception of a lack of milk, the newborn's perceived refusal to breastfeed, or a lack of support from family and friends.

These findings therefore encourage the investigators to support mothers in their choice to breastfeed from the moment they give birth, so that infant feeding practices align more closely with national and international recommendations and are as beneficial as possible for the child's health.

Furthermore, the sociodemographic characteristics of pregnant and breastfeeding women in French Guiana, as revealed by previous studies, highlight numerous vulnerabilities: one in three women experiences food insecurity during pregnancy; 12.5% of pregnancies occur before the age of 20 (compared to 1.3% in mainland France); 26% of pregnancies are not covered by PUMa, and 39% have a high multidimensional vulnerability index (compared to 5.3% in mainland France). Thus, the context of high vulnerability in perinatal care in French Guiana calls for the implementation of measures to combat social health inequalities. Health mediation is one such measure.

The investigators therefore propose the early integration of health mediation around childbirth in maternity wards.

The objective of this study is to compare the rate of exclusive breastfeeding at 1 month between women who received the intervention (exposed group) and those who did not (unexposed group).

The study hypothesis is that the health intervention will improve the rate of exclusive breastfeeding.

Being tested
postpartum breastfeeding support from a health mediator, routine health care without health mediation
Keywords
mediation, breastfeeding, post-partum, population health intervention research
Medical subject headings
Breast Feeding, Negotiating

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • postpartum breastfeeding support from a health mediatorOther

    This pilot mediation program consists of the following activities:

    • Supporting healthcare teams in providing postpartum care for women, particularly those in vulnerable situations.
    • Providing in-room support to women to assist them with breastfeeding in collaboration with the healthcare teams. The content of the support is tailored to the woman's needs and follows national guidelines. This support may be provided multiple times during the hospital stay. This individual in-room support is provided at the request of the woman and/or the healthcare team. The initial request and the content of the intervention are recorded in the woman's electronic medical record.
    • Participate weekly in the childbirth and parenting preparation workshop on breastfeeding, organized by the maternity ward and led by midwives and/or childcare assistants.
  • routine health care without health mediationOther

    routine health care for postpartum breastfeeding

Study groups in NCT07806942
Study groupRoleWhat they receive
exposed groupwomen who received health mediation services
Receives: Other: postpartum breastfeeding support from a health mediator
control groupwomen who did not receive health mediation services
Receives: Other: routine health care without health mediation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of exclusive breastfeeding at 1 month postpartum in the group of women who received health mediation support (exposed group) and in the group of women who did not receive such support (unexposed group).

    Measurement of the rate of exclusive breastfeeding using a questionnaire administred to mothers included in the study

    Measured: 1 month

Secondary outcomes (10)
  1. Rate of exclusive breastfeeding

    Measurement of the rate of exclusive breastfeeding through a questionnaire administred to mothers

    Measured: 1 month; 3 months

  2. Duration of exclusive breasfeeding

    Measurement of the duration of breastfeeding through a questionnaire administred to mothers

    Measured: 1 month; 3 months

  3. Characteristics of the exposed group, including socioeconomic and medical data and the level of health literacy.

    Description of the socioeconomics data through a questionnaire administred to mothers, and collection of medical data in the electronic medical records

    Measured: At enrollment

  4. Level of satisfaction within the maternity ward

    Score of satisfaction based on answers to a questionnaire administred to mothers included in the study within the maternity ward

    Measured: At enrollment

  5. Level of support for breastfeeding

    Score of level of support to encourage breastfeeding obtained through a questionnaire administred to mothers included in the study

    Measured: At enrollment

  6. Differences in breastfeeding rates measured in the MediMAT study compared to those measured in the ANJE Nutri study

    Calculation of breastfeeding rate calculated in the MediMAT study and comparison with breastfeeding rate calculated in the ANJE Nutri study

    Measured: 1 month; 3 months

  7. "Self-efficacy" in relation to breastfeeding

    Measurement of "self-efficacy" in relation to breastfeeding through a questionnaire administred to mothers

    Measured: 1 month

  8. Difference of feasibility of the integration of mediation into their service.

    Measurement of the difference of feasibility of the integration of mediation into their services through a questionnaire administred to healthcare staff

    Measured: At study start and at the end of enrollment in the study (May 2026 and May 2027)

  9. Changes in patients' breastfeeding practices, in the postpartum period and one year after the integration of mediation in the postpartum period.

    Measurement of changes in patients' breastfeeding practices, one year after the integration of mediation in the postpartum period through a questionnaire administred to mothers

    Measured: 12 months

  10. Changes in professional practices for supporting patients before the integration of mediation during postpartum period in the service, and one year after the integration of mediation

    Measurement of changes in professional practices for supporting patients before the integration of mediation during postpartum period in the service, and one year after the integration of mediation, through a questionnaire administred to healthcare professionals

    Measured: Before the integration of the mediation in the postpartum in the service and 12 months after the integration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2026
  2. Study start26 May 2026
  3. Primary completion31 May 2029 (estimated)
  4. Study completion31 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
960 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07806942
Sponsor's protocol ID
MédiMAT
Acronym
MédiMAT
Status last verified
Sep 2026
First submitted
2 Jun 2026
Last updated
8 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Basu S, Meghani A, Siddiqi A. Evaluating the Health Impact of Large-Scale Public Policy Changes: Classical and Novel Approaches. Annu Rev Public Health. 2017 Mar 20;38:351-370. doi: 10.1146/annurev-publhealth-031816-044208.

    PubMed 28384086
  • Dennis CL, McQueen K, Dol J, Brown H, Beck C, Shorey S. Psychometrics of the breastfeeding self-efficacy scale and short form: a systematic review. BMC Public Health. 2024 Feb 29;24(1):637. doi: 10.1186/s12889-024-17805-6.

    PubMed 38419045
  • Pugh LC, Serwint JR, Frick KD, Nanda JP, Sharps PW, Spatz DL, Milligan RA. A randomized controlled community-based trial to improve breastfeeding rates among urban low-income mothers. Acad Pediatr. 2010 Jan-Feb;10(1):14-20. doi: 10.1016/j.acap.2009.07.005. Epub 2009 Oct 23.

    PubMed 19854119
  • Chapman DJ, Morel K, Anderson AK, Damio G, Perez-Escamilla R. Breastfeeding peer counseling: from efficacy through scale-up. J Hum Lact. 2010 Aug;26(3):314-26. doi: 10.1177/0890334410369481.

    PubMed 20715336
  • McLeish J, Redshaw M. Peer support during pregnancy and early parenthood: a qualitative study of models and perceptions. BMC Pregnancy Childbirth. 2015 Oct 12;15:257. doi: 10.1186/s12884-015-0685-y.

    PubMed 26459281
  • Basurko C, Lyonnais E, Proquot M, Forsans G, Hcini N, Camara N, Galindo MS, Gatti C, Adenis A; NPTM study team; Nacher M, Savy M. Prevalence and risk factors of food insecurity during pregnancy: a multicenter survey in French Guiana. BMC Public Health. 2025 May 23;25(1):1910. doi: 10.1186/s12889-025-23173-6.

    PubMed 40410770
  • Suri S, Verlato G, Ray S. Editorial: The first 1000 days: window of opportunity for child health and development. Front Nutr. 2025 Aug 18;12:1673003. doi: 10.3389/fnut.2025.1673003. eCollection 2025. No abstract available.

    PubMed 40901286
  • Duijts L, Jaddoe VW, Hofman A, Moll HA. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010 Jul;126(1):e18-25. doi: 10.1542/peds.2008-3256. Epub 2010 Jun 21.

    PubMed 20566605
  • Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC; Lancet Breastfeeding Series Group. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016 Jan 30;387(10017):475-90. doi: 10.1016/S0140-6736(15)01024-7.

    PubMed 26869575
  • Gavine A, Shinwell SC, Buchanan P, Farre A, Wade A, Lynn F, Marshall J, Cumming SE, Dare S, McFadden A. Support for healthy breastfeeding mothers with healthy term babies. Cochrane Database Syst Rev. 2022 Oct 25;10(10):CD001141. doi: 10.1002/14651858.CD001141.pub6.

    PubMed 36282618

Questions about this trial

What is this clinical trial studying?

An observational study of Breast Feeding, Exclusive, run by Centre Hospitalier de Cayenne at 1 site in French Guiana.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in French Guiana. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Célia BASURKO, MD (+594594395050, celia.basurko@ch-cayenne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of exclusive breastfeeding at 1 month postpartum in the group of women who received health mediation support (exposed group) and in the group of women who did not receive such support (unexposed group). (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07806942, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in